Represented appellee San Francisco Women's Motorcycle Contingent in successful effort to affirm the holding of the Trademark Trial and Appeal Board that appellant McDermott did not have standing to challenge the trademark registration issued for the mark DYKES ON BIKES. McDermott v. San Francisco Women's Motorcycle Contingent, 240 Fed. Appx. 865 (Fed. Cir. 2007).

Represented Watson in pending ANDA litigation of generic version of SEASONIQUE^®. Duramed Pharmaceuticals, Inc. v. Watson Laboratories, Inc., et al., No. 3:08-cv-116 (D. Nev. filed Mar. 6, 2008).

Represents Levi Strauss & Co. (Levi) for setting brand enforcement strategies, distribution policies (including gray marketing), anti-counterfeiting efforts and enforcement of trademarks, copyrights and distribution policies in cease and desist efforts and litigation. Hundreds of matters, including over 75 lawsuits, have been handled. We have also advised Levi regarding notice and take-down issues under the DMCA.

Represented appellee Watson Pharmaceuticals, Inc. in successful defense of district court’s order dismissing Bayer’s claims of patent infringement. The Federal Circuit agreed with Watson that for a generic drug maker to infringe a method-of-use patent, the proposed label must indicate that the drug is approved (i.e., safe and effective) for the claimed method. Bayer Schering Pharma AG v. Lupin, Ltd., et al., 2012 U.S. App. LEXIS 7570, Fed. Cir. Appeal No. 2011-1143 (April 16, 2012).

Representing amicus curiae The Financial Services Roundtable in pending appeal involving the proper standard for direct patent infringement when separate actors each perform different steps of a method claim. Akamai Technologies, Inc. et al v. Limelight Networks, Inc., Fed. Cir. Appeal No. 2009-1372 (pending).

Successfully defended follow-on damages patent infringement action against Korean petrochemical concern by defeating claims on summary judgment. (N.D. Ohio).